Vuélvete ilimitado con Magzter GOLD
Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo
Intentar ORO - Gratis
IVI, ST Pharm exchange MoU,
BioSpectrum Asia
|January 2023
clinical development of COVID-19 vaccine
-
The International Vaccine Institute IVI and ST Pharm in South Korea have exchanged a Memorandum of Understanding MoU) to establish a strategic partnership and facilitate collaboration for clinical development of a pan-coronavirus mRNA vaccine. Under the MOU, IVI and ST Pharm have agreed to c
Esta historia es de la edición January 2023 de BioSpectrum Asia.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE BioSpectrum Asia
BioSpectrum Asia
SEOUL'S RISKY DRUG PRICING RESET
Drug pricing has once again moved to the centre of policy debate in South Korea, with the government recently stepping back from its proposed generic drug pricing reform.
2 mins
BioSpectrum Asia March 2026
BioSpectrum Asia
Takeda and Iambic sign $1.7 B deal to advance AI driven design of small molecules
Iambic, a US-based clinical-stage life science and technology company developing novel medicines using its artificial intelligence (AI)-driven discovery and development platform, has announced a multi-year technology and discovery collaboration agreement with Japan-based Takeda Pharma that will use Iambic's industry leading AI drug discovery models to advance a select set of high-priority small molecule programmes, initially in Takeda's Oncology and Gastrointestinal and Inflammation therapeutic areas.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
S.Biomedics announces partnership with Catalent to develop and manufacture TED-A9
US-based Catalent and South Korea-based S.Biomedics have announced a strategic partnership to support the development and manufacturing of TED-A9, S.Biomedics' allogeneic pluripotent stem-cell-derived ventral midbrain-specific dopaminergic precursor cell therapy being developed for the treatment of Parkinson's disease.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
China revises drug administration regulations to spur innovation
China has revised regulations concerning drug administration in a bid to promote drug innovation, strengthen management of online sales of medicines and reinforce drug safety supervision.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
Dr Jitendra Singh calls for missionbased India-Australia technical cooperation
After talks between India's Union Minister for Science and Technology (S&T) Dr Jitendra Singh and Australian Assistant Minister for Science, Technology and Digital Economy Dr Andrew Charlton MP, India and Australia agreed to expand and restructure their S&T partnership towards missionoriented cooperation in the field of critical and emerging technologies.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
QuidelOrtho enters strategic supply agreement to expand global immunoassay portfolio
QuidelOrtho has entered a long-term strategic supply agreement with China's Lifotronic Technology, to expand QuidelOrtho's global immunoassay portfolio and accelerate customer access to scalable, high quality, cost-efficient solutions across select markets outside the United States.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
Singapore launches first set of menopause management guidelines
The KK Women's and Children's Hospital (KKH) Maternal and Child Health Research Institute (MCHRI) has launched Singapore's first set of Guidelines on Management of the Menopause Transition.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
Pharma Essentia invests $46 M to build manufacturing plant in Puerto Rico
PharmaEssentia Corporation, a global biopharmaceutical company headquartered in Taiwan with deep expertise in the development of novel biologics for haematology and oncology, and its US subsidiary PharmaEssentia USA Corporation have announced that the global corporate Board of Directors has approved an investment of approximately $46 million to establish a new, wholly owned manufacturing subsidiary in Puerto Rico.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
Cipla partners with IISc to set up Centre for Pulmonary Medicine in India
Cipla Foundation has announced its partnership with the Indian Institute of Science (IISc) to support the establishment of a state-of-the-art Cipla Foundation Centre for Pulmonary Medicine at the Tata IISc Medical School in Bengaluru, India.
1 min
BioSpectrum Asia March 2026
BioSpectrum Asia
iX Biopharma secures $41 M contract from US govt for development of non-opioid pain treatment
Singapore-based iX Biopharma has been awarded a $40.95 million development contract by the United States Government to fund the development of Wafermine, its patented sublingual ketamine wafer for the treatment of acute moderate to severe pain.
1 min
BioSpectrum Asia March 2026
Translate
Change font size